Page last updated: 2024-10-31

ethylmaleimide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ethylmaleimide has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, AK1
Awasthi, D1
Dubey, M1
Nagarkoti, S1
Kumar, A1
Chandra, T1
Barthwal, MK1
Tripathi, AK1
Dikshit, M1
Knoepfel, L1
Steinkühler, C1
Carrì, MT1
Rotilio, G1

Other Studies

2 other studies available for ethylmaleimide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
High oxidative stress adversely affects NFκB mediated induction of inducible nitric oxide synthase in human neutrophils: Implications in chronic myeloid leukemia.
    Nitric oxide : biology and chemistry, 2016, 08-31, Volume: 58

    Topics: Dithiothreitol; Ethylmaleimide; Glutathione; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR

2016
Role of zinc-coordination and of the glutathione redox couple in the redox susceptibility of human transcription factor Sp1.
    Biochemical and biophysical research communications, 1994, Jun-15, Volume: 201, Issue:2

    Topics: Apoproteins; Base Sequence; Cell Line; Cell Nucleus; Ethylmaleimide; Glutathione; Glutathione Disulf

1994